These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21445776)

  • 1. Tumor pO₂ as a surrogate marker to identify therapeutic window during metronomic chemotherapy of 9L gliomas.
    Mupparaju S; Hou H; Lariviere JP; Swartz HM; Khan N
    Adv Exp Med Biol; 2011; 701():107-13. PubMed ID: 21445776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas.
    Mupparaju S; Hou H; Lariviere JP; Swartz H; Jounaidi Y; Khan N
    Oncol Rep; 2011 Jul; 26(1):281-6. PubMed ID: 21503586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation.
    Khan N; Li H; Hou H; Lariviere JP; Gladstone DJ; Demidenko E; Swartz HM
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):878-85. PubMed ID: 19136221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated assessment of orthotopic glioma pO(2) by multi-site EPR oximetry: a technique with the potential to guide therapeutic optimization by repeated measurements of oxygen.
    Khan N; Mupparaju S; Hou H; Williams BB; Swartz H
    J Neurosci Methods; 2012 Feb; 204(1):111-117. PubMed ID: 22079559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent low-dose chemotherapy to inhibit and oxygenate head and neck tumors.
    Khan N; Hou H; Hodge S; Kuppusamy M; Chen EY; Eastman A; Kuppusamy P; Swartz HM
    Adv Exp Med Biol; 2014; 812():105-111. PubMed ID: 24729221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle and glioma oxygenation by carbogen inhalation in rats: a longitudinal study by EPR oximetry using single-probe implantable oxygen sensors.
    Hou H; Khan N; Lariviere J; Hodge S; Chen EY; Jarvis LA; Eastman A; Williams BB; Kuppusamy P; Swartz HM
    Adv Exp Med Biol; 2014; 812():97-103. PubMed ID: 24729220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas.
    Khan N; Mupparaju S; Hekmatyar SK; Hou H; Lariviere JP; Demidenko E; Gladstone DJ; Kauppinen RA; Swartz HM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1193-200. PubMed ID: 20813466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.
    Kadayakkara DK; Janjic JM; Pusateri LK; Young WB; Ahrens ET
    Magn Reson Med; 2010 Nov; 64(5):1252-9. PubMed ID: 20860007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model.
    Wu J; Waxman DJ
    Cancer Lett; 2014 Oct; 353(2):272-80. PubMed ID: 25069038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonators.
    Hou H; Dong R; Li H; Williams B; Lariviere JP; Hekmatyar SK; Kauppinen RA; Khan N; Swartz H
    J Magn Reson; 2012 Jan; 214(1):22-8. PubMed ID: 22033225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased tumor oxygenation and drug uptake during anti-angiogenic weekly low dose cyclophosphamide enhances the anti-tumor effect of weekly tirapazamine.
    Doloff JC; Khan N; Ma J; Demidenko E; Swartz HM; Jounaidi Y
    Curr Cancer Drug Targets; 2009 Sep; 9(6):777-88. PubMed ID: 19754361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.
    Hou H; Mupparaju SP; Lariviere JP; Hodge S; Gui J; Swartz HM; Khan N
    Radiat Res; 2013 Mar; 179(3):343-51. PubMed ID: 23391148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy.
    Hou H; Lariviere JP; Demidenko E; Gladstone D; Swartz H; Khan N
    Radiother Oncol; 2009 Apr; 91(1):126-31. PubMed ID: 19013657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
    Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study.
    Dunn JF; O'Hara JA; Zaim-Wadghiri Y; Lei H; Meyerand ME; Grinberg OY; Hou H; Hoopes PJ; Demidenko E; Swartz HM
    J Magn Reson Imaging; 2002 Nov; 16(5):511-21. PubMed ID: 12412027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy.
    Abramovic Z; Hou H; Julijana K; Sentjurc M; Lariviere JP; Swartz HM; Khan N
    Adv Exp Med Biol; 2011; 701():75-82. PubMed ID: 21445772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetry.
    Hou H; Abramovic Z; Lariviere JP; Sentjurc M; Swartz H; Khan N
    Radiat Res; 2010 May; 173(5):651-8. PubMed ID: 20426665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study.
    Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Demidenko E; Lu S; Steffen RP; Swartz HM
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1503-9. PubMed ID: 15817356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry.
    Hou H; Dong R; Lariviere JP; Mupparaju SP; Swartz HM; Khan N
    J Radiat Res; 2011; 52(5):568-74. PubMed ID: 21799293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.
    Ferrer-Font L; Arias-Ramos N; Lope-Piedrafita S; Julià-Sapé M; Pumarola M; Arús C; Candiota AP
    NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28570014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.